Microcytic and macrocytic anemias Flashcards
What is the unifying pathogenic mechanism for all microcytic anemias?
Defect in RBC hemoglobin synthesis at a cellular level
What can a large RDW indicate?
In respect to microcytic anemia
The presence of a population of mixed normo/microcytic RBC population
Dimorphic RBC populations
Classically associated w/ sideroblastic anemia (myelodysplastic variant)
Microcytic RBCs arise from the mutated clone and normal rbcs from the unmutated one
Can also be seen in Pt’s w/ iron deficiency anemia who are treated w/ iron - normal cells representing those produced in response to iron supplementation, and microcytic RBCs arising from the period of iron deficient erythropoiesis
Pathway abnormailities in microcytic anemia
Defect in cellular heme synthesis
Defect in globin chain synthesis
Defect in heme synthesis in microcytic anemia
Unavailability of iron:
-iron deficiency; anemia of inflammation/chronic disease
-Defect in cellular heme/protoporpyrin synthesis
Defect in globin chain synthesis in microcytic anemia
-Thalassemias
-Thalassemia-like hemoglobinopathies: :
HbC
HbE (both β globin);
Hb Constant Spring(HbCS (α globin))2
Decreased serum iron
Increased Tf/TIBC w/ decreased Tf/Fe saturation%
Iron deficiency anemia
In early stages, MCV might be normal but is typically low
Microcytic RBCs in in iron deficiency anemia are typically also hypochromic (decreased MCHC, expanded area of central pallor)
Causes of iron malabsorption
- Celiac disease
- Autoimmune gastritis
- Bariatric surgery
- Achlorhydria (acidic pH required for optimal iron apsorption)
- Resection duodenum/proximal ileum
- Iron-refractory iron deficiency anemia (IRIDA) TMPRSS6 mutation; congenital microcytic/hypochromic anemia
Gene mutation associated w/ iron-refractory iron deficiency anemia (IRIDA)
TMPRSS6 mutation; congential microcytic/hypochromic anemia
Qualitative defects of globin synthesis
Hemoglobinopathies - characterized by the production of abnormal hemoglobin w/ an abnormal α or (more commonly) β globin chain resulting from a mutation in the globin gene
Quantitative defects of globin synthesis
Thalassemias - . As a result of a mutation in a globin gene promoter, either α or β globin chains are not produced or are produced at a decreased level that leads to imbalance between α and β globin production. It is this imbalance that causes the anemia
Thalassemia associated w/ increased levels of HbF and/or HbA2
β thalassemia syndromes
Asymptomatic Pt who is not anemic, has normal iron studies, but has MCV in the 70s
Almost certainly has a thalassemia syndrome (thalassemia trait)
HbA2 and/or HbF are elevated
β thalassemia
Target cells
Thalassemia patients other than silent carriers have “target cells” (they look like targets).
infrequent in αα/-α thalassemia, β+/β thalassemia, more common in other phenotypes.
Nucleated RBCs in thalassemia
Indicates extramedullary hematopoiesis
HbH stained w/ new methylene blue or brilliant cresy blue
HbH cannot be quantified w/ HPLC
Thalassemia that requires molecular testing
Since the most common α thalassemia syndromes do not produce an abnormal hemoglobin, the vast majority of α thalassemia patients will have normal hemoglobin quantitation. The diagnosis can be inferred by patient and family history, but requires molecular studies to confirm it. Molecular studies are almost never needed in β thalassemia
Thalassemia major
Transfusion dependent throughout life
Risk for Fe overload and complications like myocardial iron deposition-related heart disease and endocrinopathy (massive splenomagaly and extramedullary hematopoiesis)
Thalassemia minor
almost never require transfusion, are typically only mildly anemic;
many have mild splenomegaly but do not have the other complications above; and have a low risk of iron overload.
Thalassemia intermedia
Require transfusion sometimes.
They have some risk of developing the same complications as thalassemia major patients, and if they start developing those problems, they are put on chronic transfusion programs to prevent excess ERFE production and suppression of hepcidin.
Thalassemia trait
are usually not anemic at all or just barely; they have microcytosis but nothing else.
HbH disease
Clinical phenotype of thalassemia major/TDT
Frequently also have a small abount of Hb Barts (present w/ hydrops fetalis, severe TDT, and short survival)
They mostly show HbA becuase HbH is unstable
A β thalassemia syndrome with no HbA
β0 thalassemia